96452-8
LaboratoryHepatocellular carcinoma risk panel - Serum or Plasma
Definition
This assay includes a GALAD (gender, age, alpha-fetoprotein (AFP)-L3, AFP, des-gamma-carboxy prothrombin [DCP]) model score calculation to calculate the probability of hepatocellular carcinoma (HCC). The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
LOINC 6-Axis Classification
Component
Hepatocellular carcinoma risk panel
Property
-
Time Aspect
Pt
System
Ser/Plas
Scale Type
-
Method Type
N/A
Details
Class
PANEL.CHEM
Order/Observation
Order
Short Name
Hep Ca Risk Pnl SerPl
Display Name
Hepatocellular carcinoma risk panel
Related Names
Frequently Asked Questions
What is LOINC code 96452-8?
LOINC code 96452-8 identifies "Hepatocellular carcinoma risk panel - Serum or Plasma". This assay includes a GALAD (gender, age, alpha-fetoprotein (AFP)-L3, AFP, des-gamma-carboxy prothrombin [DCP]) model score calculation to calculate the probability of hepatocellular carcinoma (HCC). The GALAD model is reported to be more accurate in diagnosing HCC compared to the use of the individual markers.
What does 96452-8 measure?
This code measures Hepatocellular carcinoma risk panel in Ser/Plas. It belongs to the PANEL.CHEM class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.